Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs.

Trial Profile

Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 03 Mar 2017

At a glance

  • Drugs Donepezil (Primary) ; Galantamine (Primary) ; Rivastigmine (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms COMET-AD
  • Most Recent Events

    • 11 Apr 2016 Status changed from active, no longer recruiting to discontinued because low study accrual caused the study to be ended early.
    • 02 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top